1887

Chapter 14 : The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818883/9781555818869_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555818883/9781555818869_Chap14-2.gif

Abstract:

Genetic susceptibility, the mucosal immune system, and environmental factors such as the microbiota, stress, and diet, contribute to the pathogenesis of inflammatory bowel disease (IBD) ( ). Involvement of the microbiota has been proposed early on, as microbiota manipulation by antibiotics or probiotics can treat or alleviate IBD symptoms in humans. In experimental animal models, the gut luminal microbiota is required for the induction of chronic inflammation ( ). Different theories about how the microbiota is involved in the pathogenesis of IBD have been proposed. (1) Mutations that lead to a defective mucosal barrier function (e.g., mucus layer, innate killing, antimicrobial peptides) involve excessive translocation of commensal bacteria and triggering of proinflammatory signalling cascades. (2) Abnormal host immune regulation induces an overshooting immune response against intrinsic commensal bacteria. (3) The presence of an unidentified pathogen leads to induction of the disease or (4), a dysbiotic microbiota, characterized by an imbalance between “beneficial” and “potentially harmful” commensal bacteria, acts as a trigger or driver of the disease. The latter theory has been challenged by studies conducted in experimental rodent models: inflammatory disease conditions in the course of chronic colitis or enteropathogen infection can disrupt normal microbiota composition, induce dysbiosis, and favor overgrowth of pathogens and commensals with an increased virulence potential ( ). Therefore, dysbiosis may not only be considered as a cause but also a consequence of gut inflammation.

Citation: Stecher B. 2015. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection, p 297-320. In Conway T, Cohen P (ed), Metabolism and Bacterial Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.MBP-0008-2014
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818883.chap14
1. Blumberg R,, Powrie F . 2012. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 4 : 137rv137. [PubMed] [CrossRef]
2. Nicholson JK,, Holmes E,, Kinross J,, Burcelin R,, Gibson G,, Jia W,, Pettersson S . 2012. Host-gut microbiota metabolic interactions. Science 336 : 1262 1267.[PubMed] [CrossRef]
3. Cho I,, Blaser MJ . 2012. The human microbiome: at the interface of health and disease. Nat Rev Genet 13 : 260 270.[PubMed] [CrossRef]
4. Lozupone CA,, Stombaugh JI,, Gordon JI,, Jansson JK,, Knight R . 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489 : 220 230.[PubMed] [CrossRef]
5. Dethlefsen L,, Relman DA . 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108( Suppl 1) : 4554 4561.[PubMed] [CrossRef]
6. Hill DA,, Hoffmann C,, Abt MC,, Du Y,, Kobuley D,, Kirn TJ,, Bushman FD,, Artis D . 2010. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3 : 148 158.[PubMed] [CrossRef]
7. Wu GD,, Chen J,, Hoffmann C,, Bittinger K,, Chen YY,, Keilbaugh SA,, Bewtra M,, Knights D,, Walters WA,, Knight R,, Sinha R,, Gilroy E,, Gupta K,, Baldassano R,, Nessel L,, Li H,, Bushman FD,, Lewis JD . 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 : 105 108.[PubMed] [CrossRef]
8. Walker AW,, Ince J,, Duncan SH,, Webster LM,, Holtrop G,, Ze X,, Brown D,, Stares MD,, Scott P,, Bergerat A,, Louis P,, McIntosh F,, Johnstone AM,, Lobley GE,, Parkhill J,, Flint HJ . 2011. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5 : 220 230.[PubMed] [CrossRef]
9. Zhang X,, Zhao Y,, Zhang M,, Pang X,, Xu J,, Kang C,, Li M,, Zhang C,, Zhang Z,, Zhang Y,, Li X,, Ning G,, Zhao L . 2012. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS ONE 7 : e42529. [PubMed] [CrossRef]
10. Stecher B,, Berry D,, Loy A . 2013. Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiol Rev 37 : 793 829.[PubMed] [CrossRef]
11. Stecher B,, Maier L,, Hardt WD . 2013. ‘Blooming’ in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11 : 277 284.[PubMed] [CrossRef]
12. Hooper LV,, Littman DR,, Macpherson AJ . 2012. Interactions between the microbiota and the immune system. Science 336 : 1268 1273.[PubMed] [CrossRef]
13. Manichanh C,, Borruel N,, Casellas F,, Guarner F . 2012. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9 : 599 608.[PubMed] [CrossRef]
14. Winter SE,, Lopez CA,, Baumler AJ . 2013. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14 : 319 327.[PubMed] [CrossRef]
15. Strober W,, Fuss I,, Mannon P . 2007. The fundamental basis of inflammatory bowel disease. Journal Clin Invest 117 : 514 521.[PubMed] [CrossRef]
16. Sartor RB . 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 : 577 594.[PubMed] [CrossRef]
17. Sansonetti PJ . 2008. Host-bacteria homeostasis in the healthy and inflamed gut. Current opinion in gastroenterology 24 : 435 439.[PubMed] [CrossRef]
18. Peach S,, Lock MR,, Katz D,, Todd IP,, Tabaqchali S . 1978. Mucosal-associated bacterial flora of the intestine in patients with Crohn’s disease and in a control group. Gut 19 : 1034 1042.[PubMed] [CrossRef]
19. Giaffer MH,, Holdsworth CD,, Duerden BI . 1991. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 35 : 238 243.[PubMed] [CrossRef]
20. Wensinck F,, Custers-van L,, Poppelaars-Kustermans PA,, Schroder AM . 1981. The faecal flora of patients with Crohn’s disease. J Hyg (Lond) 87 : 1 12.[PubMed] [CrossRef]
21. Frank DN,, St Amand AL,, Feldman RA,, Boedeker EC,, Harpaz N,, Pace NR . 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 : 13780 13785.[PubMed] [CrossRef]
22. Qin J,, Li R,, Raes J,, Arumugam M,, Burgdorf KS,, Manichanh C,, Nielsen T,, Pons N,, Levenez F,, Yamada T,, Mende DR,, Li J,, Xu J,, Li S,, Li D,, Cao J,, Wang B,, Liang H,, Zheng H,, Xie Y,, Tap J,, Lepage P,, Bertalan M,, Batto JM,, Hansen T,, Le Paslier D,, Linneberg A,, Nielsen HB,, Pelletier E,, Renault P,, Sicheritz-Ponten T,, Turner K,, Zhu H,, Yu C,, Jian M,, Zhou Y,, Li Y,, Zhang X,, Qin N,, Yang H,, Wang J,, Brunak S,, Dore J,, Guarner F,, Kristiansen K,, Pedersen O,, Parkhill J,, Weissenbach J,, Bork P,, Ehrlich SD . 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 : 59 65.[PubMed] [CrossRef]
23. Fyderek K,, Strus M,, Kowalska-Duplaga K,, Gosiewski T,, Wedrychowicz A,, Jedynak-Wasowicz U,, Sladek M,, Pieczarkowski S,, Adamski P,, Kochan P,, Heczko PB . 2009. Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol 15 : 5287 5294.[PubMed] [CrossRef]
24. Gosiewski T,, Strus M,, Fyderek K,, Kowalska-Duplaga K,, Wedrychowicz A,, Jedynak-Wasowicz U,, Sladek M,, Pieczarkowski S,, Adamski P,, Heczko PB . 2012. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 54 : 20 27.[PubMed] [CrossRef]
25. Baumgart M,, Dogan B,, Rishniw M,, Weitzman G,, Bosworth B,, Yantiss R,, Orsi RH,, Wiedmann M,, McDonough P,, Kim SG,, Berg D,, Schukken Y,, Scherl E,, Simpson KW . 2007. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J 1 : 403 418.[PubMed] [CrossRef]
26. Sokol H,, Seksik P,, Rigottier-Gois L,, Lay C,, Lepage P,, Podglajen I,, Marteau P,, Dore J . 2006. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12 : 106 111.[PubMed] [CrossRef]
27. Sokol H,, Seksik P,, Furet JP,, Firmesse O,, Nion-Larmurier I,, Beaugerie L,, Cosnes J,, Corthier G,, Marteau P,, Dore J . 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15 : 1183 1189.[PubMed] [CrossRef]
28. Fujimoto T,, Imaeda H,, Takahashi K,, Kasumi E,, Bamba S,, Fujiyama Y,, Andoh A . 2013. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn’s disease. J Gastroenterol Hepatol 28 : 613 619.[PubMed] [CrossRef]
29. Duncan SH,, Hold GL,, Harmsen HJ,, Stewart CS,, Flint HJ . 2002. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 52 : 2141 2146.[PubMed] [CrossRef]
30. Bibiloni R,, Mangold M,, Madsen KL,, Fedorak RN,, Tannock GW . 2006. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn’s disease and ulcerative colitis patients. J Med Microbiol 55 : 1141 1149.[PubMed] [CrossRef]
31. Swidsinski A,, Weber J,, Loening-Baucke V,, Hale LP,, Lochs H . 2005. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43 : 3380 3389.[PubMed] [CrossRef]
32. Darfeuille-Michaud A,, Boudeau J,, Bulois P,, Neut C,, Glasser AL,, Barnich N,, Bringer MA,, Swidsinski A,, Beaugerie L,, Colombel JF . 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127 : 412 421.[PubMed] [CrossRef]
33. Kotlowski R,, Bernstein CN,, Sepehri S,, Krause DO . 2007. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56 : 669 675.[PubMed] [CrossRef]
34. Maharshak N,, Packey CD,, Ellermann M,, Manick S,, Siddle JP,, Huh EY,, Plevy S,, Sartor RB,, Carroll IM . 2013. Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes 4 : 316 324.[PubMed] [CrossRef]
35. Garrett WS,, Gallini CA,, Yatsunenko T,, Michaud M,, DuBois A,, Delaney ML,, Punit S,, Karlsson M,, Bry L,, Glickman JN,, Gordon JI,, Onderdonk AB,, Glimcher LH . 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8 : 292 300.[PubMed] [CrossRef]
36. Lupp C,, Robertson ML,, Wickham ME,, Sekirov I,, Champion OL,, Gaynor EC,, Finlay BB . 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe 2 : 119 129.[PubMed] [CrossRef]
37. Berry D,, Schwab C,, Milinovich G,, Reichert J,, Ben Mahfoudh K,, Decker T,, Engel M,, Hai B,, Hainzl E,, Heider S,, Kenner L,, Muller M,, Rauch I,, Strobl B,, Wagner M,, Schleper C,, Urich T,, Loy A . 2012. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J 6 : 2091 2096.[PubMed] [CrossRef]
38. Stecher B,, Robbiani R,, Walker AW,, Westendorf AM,, Barthel M,, Kremer M,, Chaffron S,, Macpherson AJ,, Buer J,, Parkhill J,, Dougan G,, von Mering C,, Hardt WD . 2007. Salmonella enterica Serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5 : e244. [PubMed] [CrossRef]
39. Barman M,, Unold D,, Shifley K,, Amir E,, Hung K,, Bos N,, Salzman N . 2008. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76 : 907 915.[PubMed] [CrossRef]
40. Molloy MJ,, Grainger JR,, Bouladoux N,, Hand TW,, Koo LY,, Naik S,, Quinones M,, Dzutsev AK,, Gao JL,, Trinchieri G,, Murphy PM,, Belkaid Y . 2013. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 14 : 318 328.[PubMed] [CrossRef]
41. Ma AT,, Mekalanos JJ . In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A 107 : 4365 4370.[PubMed] [CrossRef]
42. Lawley TD,, Clare S,, Walker AW,, Goulding D,, Stabler RA,, Croucher N,, Mastroeni P,, Scott P,, Raisen C,, Mottram L,, Fairweather NF,, Wren BW,, Parkhill J,, Dougan G . 2009. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 77 : 3661 3669.[PubMed] [CrossRef]
43. Gevers D,, Kugathasan S,, Denson LA,, Vazquez-Baeza Y,, Van Treuren W,, Ren B,, Schwager E,, Knights D,, Song SJ,, Yassour M,, Morgan XC,, Kostic AD,, Luo C,, Gonzalez A,, McDonald D,, Haberman Y,, Walters T,, Baker S,, Rosh J,, Stephens M,, Heyman M,, Markowitz J,, Baldassano R,, Griffiths A,, Sylvester F,, Mack D,, Kim S,, Crandall W,, Hyams J,, Huttenhower C,, Knight R,, Xavier RJ . 2014. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15 : 382 392.[PubMed] [CrossRef]
44. Adlerberth I . 2008. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program 62 : 13 29; discussion 29–33.[PubMed] [CrossRef]
45. Palmer C,, Bik EM,, Digiulio DB,, Relman DA,, Brown PO . 2007. Development of the human infant intestinal microbiota. PLoS Biol 5 : e177. [PubMed] [CrossRef]
46. Dominguez-Bello MG,, Blaser MJ,, Ley RE,, Knight R . 2011. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 140 : 1713 1719.[PubMed] [CrossRef]
47. Arumugam M,, Raes J,, Pelletier E,, Le Paslier D,, Yamada T,, Mende DR,, Fernandes GR,, Tap J,, Bruls T,, Batto JM,, Bertalan M,, Borruel N,, Casellas F,, Fernandez L,, Gautier L,, Hansen T,, Hattori M,, Hayashi T,, Kleerebezem M,, Kurokawa K,, Leclerc M,, Levenez F,, Manichanh C,, Nielsen HB,, Nielsen T,, Pons N,, Poulain J,, Qin J,, Sicheritz-Ponten T,, Tims S,, Torrents D,, Ugarte E,, Zoetendal EG,, Wang J,, Guarner F,, Pedersen O,, de Vos WM,, Brunak S,, Dore J,, Consortium M,, Weissenbach J,, Ehrlich SD,, Bork P,, Antolin M,, Artiguenave F,, Blottiere HM,, Almeida M,, Brechot C,, Cara C,, Chervaux C,, Cultrone A,, Delorme C,, Denariaz G,, Dervyn R,, Foerstner KU,, Friss C,, van de Guchte M,, Guedon E,, Haimet F,, Huber W,, van Hylckama-Vlieg J,, Jamet A,, Juste C,, Kaci G,, Knol J,, Lakhdari O,, Layec S,, Le Roux K,, Maguin E,, Merieux A,, Melo Minardi R,, M’Rini C,, Muller J,, Oozeer R,, Parkhill J,, Renault P,, Rescigno M,, Sanchez N,, Sunagawa S,, Torrejon A,, Turner K,, Vandemeulebrouck G,, Varela E,, Winogradsky Y,, Zeller G . 2011. Enterotypes of the human gut microbiome. Nature 473 : 174 180.[PubMed] [CrossRef]
48. Vollaard EJ,, Clasener HA . 1994. Colonization resistance. Antimicrob Agents Chemother 38 : 409 414.[PubMed] [CrossRef]
49. Buffie CG,, Jarchum I,, Equinda M,, Lipuma L,, Gobourne A,, Viale A,, Ubeda-Morant C,, Xavier J,, Pamer EG . 2012. Profound alterations of intestinal microbiota following a single dose of Clindamycin results in sustained susceptibility to C. difficile-induced colitis. Infect Immun 80 : 62 73.[PubMed] [CrossRef]
50. Taur Y,, Xavier JB,, Lipuma L,, Ubeda C,, Goldberg J,, Gobourne A,, Lee YJ,, Dubin KA,, Socci ND,, Viale A,, Perales MA,, Jenq RR,, van den Brink MR,, Pamer EG . 2012. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55 : 905 914.[PubMed] [CrossRef]
51. Keseler IM,, Bonavides-Martinez C,, Collado-Vides J,, Gama-Castro S,, Gunsalus RP,, Johnson DA,, Krummenacker M,, Nolan LM,, Paley S,, Paulsen IT,, Peralta-Gil M,, Santos-Zavaleta A,, Shearer AG,, Karp PD . 2009. EcoCyc: a comprehensive view of Escherichia coli biology. Nucleic Acids Res 37 : D464 D470.[PubMed] [CrossRef]
52. Rasko DA,, Rosovitz MJ,, Myers GS,, Mongodin EF,, Fricke WF,, Gajer P,, Crabtree J,, Sebaihia M,, Thomson NR,, Chaudhuri R,, Henderson IR,, Sperandio V,, Ravel J . 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190 : 6881 6893.[PubMed] [CrossRef]
53. Vieira G,, Sabarly V,, Bourguignon PY,, Durot M,, Le Fevre F,, Mornico D,, Vallenet D,, Bouvet O,, Denamur E,, Schachter V,, Medigue C . 2011. Core and panmetabolism in Escherichia coli . J Bacteriol 193 : 1461 1472.[PubMed] [CrossRef]
54. Chang DE,, Smalley DJ,, Tucker DL,, Leatham MP,, Norris WE,, Stevenson SJ,, Anderson AB,, Grissom JE,, Laux DC,, Cohen PS,, Conway T . 2004. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A 101 : 7427 7432.[PubMed] [CrossRef]
55. Unden G,, Bongaerts J . 1997. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta 1320 : 217 234.[PubMed] [CrossRef]
56. Neidhardt FC CIR,, Ingraham JL,, Edmund CCL,, Brooks Low K,, Magasanik B,, Reznikoff WS,, Riley M,, Schaechter M,, Umbarger HE . 1995. Escherichia coli and Salmonella. ASM Press, Washington, DC.
57. Qin X,, Galloway-Pena JR,, Sillanpaa J,, Roh JH,, Nallapareddy SR,, Chowdhury S,, Bourgogne A,, Choudhury T,, Muzny DM,, Buhay CJ,, Ding Y,, Dugan-Rocha S,, Liu W,, Kovar C,, Sodergren E,, Highlander S,, Petrosino JF,, Worley KC,, Gibbs RA,, Weinstock GM,, Murray BE . 2012. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol 12 : 135. [PubMed] [CrossRef]
58. Ramsey M,, Hartke A,, Huycke M, . 2014. The physiology and metabolism of Enterococci. In Gilmore MS,, Clewell DB,, Ike Y,, Shankar N (ed), Enterococci: From commensals to leading causes of drug resistant infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014–. 2014 Feb 15.
59. Pritchard GG,, Wimpenny JW . 1978. Cytochrome formation, oxygen-induced proton extrusion and respiratory activity in Streptococcus faecalis var. zymogenes grown in the presence of haematin. J Gen Microbiol 104 : 15 22.[PubMed] [CrossRef]
60. Bourgogne A,, Garsin DA,, Qin X,, Singh KV,, Sillanpaa J,, Yerrapragada S,, Ding Y,, Dugan-Rocha S,, Buhay C,, Shen H,, Chen G,, Williams G,, Muzny D,, Maadani A,, Fox KA,, Gioia J,, Chen L,, Shang Y,, Arias CA,, Nallapareddy SR,, Zhao M,, Prakash VP,, Chowdhury S,, Jiang H,, Gibbs RA,, Murray BE,, Highlander SK,, Weinstock GM . 2008. Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol 9 : R110. [PubMed] [CrossRef]
61. Rigottier-Gois L . 2013. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J 7 : 1256 1261.[PubMed] [CrossRef]
62. Karhausen J,, Furuta GT,, Tomaszewski JE,, Johnson RS,, Colgan SP,, Haase VH . 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. Journal Clin Invest 114 : 1098 1106.[PubMed] [CrossRef]
63. He G,, Shankar RA,, Chzhan M,, Samouilov A,, Kuppusamy P,, Zweier JL . 1999. Noninvasive measurement of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc Natl Acad Sci U S A 96 : 4586 4591.[PubMed] [CrossRef]
64. Handa K,, Ohmura M,, Nishime C,, Hishiki T,, Nagahata Y,, Kawai K,, Suemizu H,, Nakamura M,, Wakui M,, Kitagawa Y,, Suematsu M,, Tsukada K . 2010. Phosphorescence-assisted microvascular O(2) measurements reveal alterations of oxygen demand in human metastatic colon cancer in the liver of superimmunodeficient NOG mice. Adv Exp Med Biol 662 : 423 429.[PubMed]
65. Hartman AL,, Lough DM,, Barupal DK,, Fiehn O,, Fishbein T,, Zasloff M,, Eisen JA . 2009. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A 106 : 17187 17192.[PubMed] [CrossRef]
66. Hensel M,, Hinsley AP,, Nikolaus T,, Sawers G,, Berks BC . 1999. The genetic basis of tetrathionate respiration in Salmonella Typhimurium. Molecular Microbiol 32 : 275 287.[PubMed] [CrossRef]
67. Fang FC . 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2 : 820 832.[PubMed] [CrossRef]
68. Kuwano Y,, Kawahara T,, Yamamoto H,, Teshima-Kondo S,, Tominaga K,, Masuda K,, Kishi K,, Morita K,, Rokutan K . 2006. Interferon-gamma activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells. Am J Physiol Cell Physiol 290 : C433 C443.[PubMed] [CrossRef]
69. Harper RW,, Xu C,, Eiserich JP,, Chen Y,, Kao CY,, Thai P,, Setiadi H,, Wu R . 2005. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 579 : 4911 4917.[PubMed] [CrossRef]
70. Nathan C . 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6 : 173 182.[PubMed] [CrossRef]
71. Zhu H,, Li YR . 2012. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood) 237 : 474 480.[PubMed] [CrossRef]
72. Lundberg JO,, Hellstrom PM,, Lundberg JM,, Alving K . 1994. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344 : 1673 1674.[PubMed] [CrossRef]
73. Songhet P,, Barthel M,, Rohn TA,, Van Maele L,, Cayet D,, Sirard JC,, Bachmann M,, Kopf M,, Hardt WD . 2010. IL-17A/F-signaling does not contribute to the initial phase of mucosal inflammation triggered by S. Typhimurium. PLoS ONE 5 : e13804. [PubMed] [CrossRef]
74. Winter SE,, Thiennimitr P,, Winter MG,, Butler BP,, Huseby DL,, Crawford RW,, Russell JM,, Bevins CL,, Adams LG,, Tsolis RM,, Roth JR,, Baumler AJ . 2010. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467 : 426 429.[PubMed] [CrossRef]
75. Levitt MD,, Furne J,, Springfield J,, Suarez F,, DeMaster E . 1999. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J ClinInvest 104 : 1107 1114.[PubMed] [CrossRef]
76. Szabo C,, Ischiropoulos H,, Radi R . 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6 : 662 680.[PubMed] [CrossRef]
77. Rajagopalan KV,, Johnson JL . 1992. The pterin molybdenum cofactors. J Biol Chem 267 : 10199 10202.[PubMed]
78. Winter SE,, Winter MG,, Xavier MN,, Thiennimitr P,, Poon V,, Keestra AM,, Laughlin RC,, Gomez G,, Wu J,, Lawhon SD,, Popova IE,, Parikh SJ,, Adams LG,, Tsolis RM,, Stewart VJ,, Baumler AJ . 2013. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339 : 708 711.[PubMed] [CrossRef]
79. Bertin Y,, Girardeau JP,, Chaucheyras-Durand F,, Lyan B,, Pujos-Guillot E,, Harel J,, Martin C . 2011. Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. Environ Microbiol 13 : 365 377.[PubMed] [CrossRef]
80. Thiennimitr P,, Winter SE,, Winter MG,, Xavier MN,, Tolstikov V,, Huseby DL,, Sterzenbach T,, Tsolis RM,, Roth JR,, Baumler AJ . 2011. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A 108 : 17480 17485.[PubMed] [CrossRef]
81. Kofoid E,, Rappleye C,, Stojiljkovic I,, Roth J . 1999. The 17-gene ethanolamine (eut) operon of Salmonella Typhimurium encodes five homologues of carboxysome shell proteins. J Bacteriol 181 : 5317 5329.[PubMed]
82. Price-Carter M,, Tingey J,, Bobik TA,, Roth JR . 2001. The alternative electron acceptor tetrathionate supports B12-dependent anaerobic growth of Salmonella enterica serovar typhimurium on ethanolamine or 1,2-propanediol. J Bacteriol 183 : 2463 2475.[PubMed] [CrossRef]
83. Roof DM,, Roth JR . 1988. Ethanolamine utilization in Salmonella typhimurium. J Bacteriol 170 : 3855 3863.[PubMed]
84. Tsoy O,, Ravcheev D,, Mushegian A . 2009. Comparative genomics of ethanolamine utilization. J Bacteriol 191 : 7157 7164.[PubMed] [CrossRef]
85. Garsin DA . 2010. Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat Rev Microbiol 8 : 290 295.[PubMed] [CrossRef]
86. Pitts AC,, Tuck LR,, Faulds-Pain A,, Lewis RJ,, Marles-Wright J . 2012. Structural insight into the Clostridium difficile ethanolamine utilisation microcompartment. PLoS ONE 7 : e48360. [PubMed] [CrossRef]
87. Del Papa MF,, Perego M . 2008. Ethanolamine activates a sensor histidine kinase regulating its utilization in Enterococcus faecalis . Journal Bacteriol 190 : 7147 7156.[PubMed] [CrossRef]
88. Bradbeer C . 1965. The clostridial fermentations of choline and ethanolamine. II. Requirement for a cobamide coenzyme by an ethanolamine deaminase. J Biol Chem 240 : 4675 4681.[PubMed]
89. Johansson ME,, Ambort D,, Pelaseyed T,, Schutte A,, Gustafsson JK,, Ermund A,, Subramani DB,, Holmen-Larsson JM,, Thomsson KA,, Bergstrom JH,, van der Post S,, Rodriguez-Pineiro AM,, Sjovall H,, Backstrom M,, Hansson GC . 2011. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 68 : 3635 3641.[PubMed] [CrossRef]
90. McGuckin MA,, Linden SK,, Sutton P,, Florin TH . 2011. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9 : 265 278.[PubMed] [CrossRef]
91. Allen A,, Cunliffe WJ,, Pearson JP,, Sellers LA,, Ward R . 1984. Studies on gastrointestinal mucus. Scand J Gastroenterol Suppl 93 : 101 113.[PubMed]
92. Stecher B,, Barthel M,, Schlumberger MC,, Haberli L,, Rabsch W,, Kremer M,, Hardt WD . 2008. Motility allows S. Typhimurium to benefit from the mucosal defence. Cell Microbiol 10 : 1166 1180.[PubMed] [CrossRef]
93. Zarepour M,, Bhullar K,, Montero M,, Ma C,, Huang T,, Velcich A,, Xia L,, Vallance BA . 2013. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis. Infect Immun 81 : 3672 3683.[PubMed] [CrossRef]
94. Bergstrom KS,, Kissoon-Singh V,, Gibson DL,, Ma C,, Montero M,, Sham HP,, Ryz N,, Huang T,, Velcich A,, Finlay BB,, Chadee K,, Vallance BA . 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 6 : e1000902. [PubMed] [CrossRef]
95. Songhet P,, Barthel M,, Stecher B,, Muller AJ,, Kremer M,, Hansson GC,, Hardt WD . 2011. Stromal IFN-gammaR-signaling modulates goblet cell function during Salmonella Typhimurium infection. PLoS ONE 6 : e22459. [PubMed] [CrossRef]
96. Png CW,, Linden SK,, Gilshenan KS,, Zoetendal EG,, McSweeney CS,, Sly LI,, McGuckin MA,, Florin TH . 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105 : 2420 2428.[PubMed] [CrossRef]
97. Schwab C,, Berry D,, Rauch I,, Rennisch I,, Ramesmayer J,, Hainzl E,, Heider S,, Decker T,, Kenner L,, Muller M,, Strobl B,, Wagner M,, Schleper C,, Loy A,, Urich T . 2014. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J 8 : 1101 1114.[PubMed] [CrossRef]
98. Derrien M,, Vaughan EE,, Plugge CM,, de Vos WM . 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54 : 1469 1476.[PubMed] [CrossRef]
99. Robertson BR,, O’Rourke JL,, Neilan BA,, Vandamme P,, On SL,, Fox JG,, Lee A . 2005. Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int J Syst Evol Microbiol 55 : 1199 1204.[PubMed] [CrossRef]
100. Berry D,, Stecher B,, Schintlmeister A,, Reichert J,, Brugiroux S,, Wild B,, Wanek W,, Richter A,, Rauch I,, Decker T,, Loy A,, Wagner M . 2013. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc Natl Acad Sci U S A 110 : 4720 4725.[PubMed] [CrossRef]
101. Ruseler-van Embden JG,, van Lieshout LM . 1987. Increased faecal glycosidases in patients with Crohn’s disease. Digestion 37 : 43 50.[PubMed] [CrossRef]
102. Deatherage Kaiser BL,, Li J,, Sanford JA,, Kim YM,, Kronewitter SR,, Jones MB,, Peterson CT,, Peterson SN,, Frank BC,, Purvine SO,, Brown JN,, Metz TO,, Smith RD,, Heffron F,, Adkins JN . 2013. A multi-omic view of host-pathogen-commensal interplay in mediated intestinal infection. PLoS ONE 8 : e67155. [PubMed] [CrossRef]
103. Ng KM,, Ferreyra JA,, Higginbottom SK,, Lynch JB,, Kashyap PC,, Gopinath S,, Naidu N,, Choudhury B,, Weimer BC,, Monack DM,, Sonnenburg JL . 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502 : 96 99.[PubMed] [CrossRef]
104. Rivera-Chavez F,, Winter SE,, Lopez CA,, Xavier MN,, Winter MG,, Nuccio SP,, Russell JM,, Laughlin RC,, Lawhon SD,, Sterzenbach T,, Bevins CL,, Tsolis RM,, Harshey R,, Adams LG,, Baumler AJ . 2013. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog 9 : e1003267. [PubMed] [CrossRef]
105. Zipfel PF,, Hallstrom T,, Riesbeck K . 2013. Human complement control and complement evasion by pathogenic microbes–tipping the balance. Mol Immunol 56 : 152 160.[PubMed] [CrossRef]
106. Stecher B,, Hardt WD . 2008. The role of microbiota in infectious disease. Trends Microbiol 16 : 107 114.[PubMed] [CrossRef]
107. Andrews NC,, Schmidt PJ . 2007. Iron homeostasis. Annu Rev Physiol 69 : 69 85.[PubMed] [CrossRef]
108. Galy B,, Ferring-Appel D,, Becker C,, Gretz N,, Grone HJ,, Schumann K,, Hentze MW . 2013. Iron regulatory proteins control a mucosal block to intestinal iron absorption. Cell Rep 3 : 844 857.[PubMed] [CrossRef]
109. De Domenico I,, Ward DM,, Kaplan J . 2011. Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis 31 : 272 279.[PubMed] [CrossRef]
110. Neilands JB . 1995. Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 270 : 26723 26726.[PubMed] [CrossRef]
111. Muller SI,, Valdebenito M,, Hantke K . 2009. Salmochelin, the long-overlooked catecholate siderophore of Salmonella. Biometals 22 : 691 695.[PubMed] [CrossRef]
112. Raffatellu M,, George MD,, Akiyama Y,, Hornsby MJ,, Nuccio SP,, Paixao TA,, Butler BP,, Chu H,, Santos RL,, Berger T,, Mak TW,, Tsolis RM,, Bevins CL,, Solnick JV,, Dandekar S,, Baumler AJ . 2009. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5 : 476 486.[PubMed] [CrossRef]
113. Loetscher Y,, Wieser A,, Lengefeld J,, Kaiser P,, Schubert S,, Heikenwalder M,, Hardt WD,, Stecher B . 2012. Salmonella transiently reside in luminal neutrophils in the inflamed gut. PLoS ONE 7 : e34812. [PubMed] [CrossRef]
114. Goetz DH,, Holmes MA,, Borregaard N,, Bluhm ME,, Raymond KN,, Strong RK . 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10 : 1033 1043.[CrossRef]
115. Gill N,, Ferreira RB,, Antunes LC,, Willing BP,, Sekirov I,, Al-Zahrani F,, Hartmann M,, Finlay BB . 2012. Neutrophil elastase alters the murine gut microbiota resulting in enhanced salmonella colonization. PLoS ONE 7 : e49646. [PubMed] [CrossRef]
116. Corbin BD,, Seeley EH,, Raab A,, Feldmann J,, Miller MR,, Torres VJ,, Anderson KL,, Dattilo BM,, Dunman PM,, Gerads R,, Caprioli RM,, Nacken W,, Chazin WJ,, Skaar EP . 2008. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319 : 962 965.[PubMed] [CrossRef]
117. Kehl-Fie TE,, Chitayat S,, Hood MI,, Damo S,, Restrepo N,, Garcia C,, Munro KA,, Chazin WJ,, Skaar EP . 2011. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus . Cell Host Microbe 10 : 158 164.[PubMed] [CrossRef]
118. Liu JZ,, Jellbauer S,, Poe AJ,, Ton V,, Pesciaroli M,, Kehl-Fie TE,, Restrepo NA,, Hosking MP,, Edwards RA,, Battistoni A,, Pasquali P,, Lane TE,, Chazin WJ,, Vogl T,, Roth J,, Skaar EP,, Raffatellu M . 2012. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 11 : 227 239.[PubMed] [CrossRef]
119. Wehkamp J,, Salzman NH,, Porter E,, Nuding S,, Weichenthal M,, Petras RE,, Shen B,, Schaeffeler E,, Schwab M,, Linzmeier R,, Feathers RW,, Chu H,, Lima H Jr,, Fellermann K,, Ganz T,, Stange EF,, Bevins CL . 2005. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci U S A 102 : 18129 18134.[PubMed] [CrossRef]
120. Salzman NH,, Hung K,, Haribhai D,, Chu H,, Karlsson-Sjoberg J,, Amir E,, Teggatz P,, Barman M,, Hayward M,, Eastwood D,, Stoel M,, Zhou Y,, Sodergren E,, Weinstock GM,, Bevins CL,, Williams CB,, Bos NA . 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11 : 76 83.[PubMed] [CrossRef]
121. Rahman A,, Fahlgren A,, Sundstedt C,, Hammarstrom S,, Danielsson A,, Hammarstrom ML . 2011. Chronic colitis induces expression of beta-defensins in murine intestinal epithelial cells. Clin Exp Immunol 163 : 123 130.[PubMed] [CrossRef]
122. Ho S,, Pothoulakis C,, Koon HW . 2013. Antimicrobial peptides and colitis. Curr Pharm Des 19 : 40 47.[PubMed]
123. Joly S,, Maze C,, McCray PB Jr,, Guthmiller JM . 2004. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42 : 1024 1029.[PubMed] [CrossRef]
124. Salzman NH,, Ghosh D,, Huttner KM,, Paterson Y,, Bevins CL . 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422 : 522 526.[PubMed] [CrossRef]
125. Sperandio B,, Regnault B,, Guo J,, Zhang Z,, Stanley SL Jr,, Sansonetti PJ,, Pedron T . 2008. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. Journal Exp Med 205 : 1121 1132.[PubMed] [CrossRef]
126. Pazgier M,, Hoover DM,, Yang D,, Lu W,, Lubkowski J . 2006. Human beta-defensins. Cell Mol Life Sci 63 : 1294 1313.[PubMed] [CrossRef]
127. Cash HL,, Whitham CV,, Behrendt CL,, Hooper LV . 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 : 1126 1130.[PubMed] [CrossRef]
128. Stelter C,, Kappeli R,, Konig C,, Krah A,, Hardt WD,, Stecher B,, Bumann D . 2011. Salmonella-induced mucosal lectin regIIIbeta kills competing gut microbiota. PLoS ONE 6 : e20749. [PubMed] [CrossRef]
129. Miki T,, Holst O,, Hardt WD . 2012. The bactericidal activity of the C-type lectin RegIIIbeta against Gram-negative bacteria involves binding to lipid A. J Biol Chem 287 : 34844 34855.[PubMed] [CrossRef]
130. Vaishnava S,, Yamamoto M,, Severson KM,, Ruhn KA,, Yu X,, Koren O,, Ley R,, Wakeland EK,, Hooper LV . 2011. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334 : 255 258.[PubMed] [CrossRef]
131. Craven M,, Egan CE,, Dowd SE,, McDonough SP,, Dogan B,, Denkers EY,, Bowman D,, Scherl EJ,, Simpson KW . 2012. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn’s disease. PLoS ONE 7 : e41594. [PubMed] [CrossRef]
132. Chow J,, Mazmanian SK . 2010. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7 : 265 276.[PubMed] [CrossRef]
133. Ayres JS,, Trinidad NJ,, Vance RE . 2012. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 18 : 799 806.[PubMed] [CrossRef]
134. Barnich N,, Darfeuille-Michaud A . 2007. Adherent-invasive Escherichia coli and Crohn’s disease. Curr Opin Gastroenterol 23 : 16 20.[PubMed] [CrossRef]
135. Darfeuille-Michaud A . 2002. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol 292 : 185 193.[PubMed] [CrossRef]
136. Tabaqchali S,, O’Donoghue DP,, Bettelheim KA . 1978. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 19 : 108 113.[PubMed] [CrossRef]
137. Wehkamp J,, Stange EF . 2006. A new look at Crohn’s disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072 : 321 331.[PubMed] [CrossRef]
138. Barnich N,, Carvalho FA,, Glasser AL,, Darcha C,, Jantscheff P,, Allez M,, Peeters H,, Bommelaer G,, Desreumaux P,, Colombel JF,, Darfeuille-Michaud A . 2007. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. Journal Clin Invest 117 : 1566 1574.[PubMed] [CrossRef]
139. Carvalho FA,, Barnich N,, Sivignon A,, Darcha C,, Chan CH,, Stanners CP,, Darfeuille-Michaud A . 2009. Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 206 : 2179 2189.[PubMed] [CrossRef]
140. Vijay-Kumar M,, Sanders CJ,, Taylor RT,, Kumar A,, Aitken JD,, Sitaraman SV,, Neish AS,, Uematsu S,, Akira S,, Williams IR,, Gewirtz AT . 2007. Deletion of TLR5 results in spontaneous colitis in mice. J Clinical Invest 117 : 3909 3921.[PubMed] [CrossRef]
141. Carvalho FA,, Koren O,, Goodrich JK,, Johansson ME,, Nalbantoglu I,, Aitken JD,, Su Y,, Chassaing B,, Walters WA,, Gonzalez A,, Clemente JC,, Cullender TC,, Barnich N,, Darfeuille-Michaud A,, Vijay-Kumar M,, Knight R,, Ley RE,, Gewirtz AT . 2012. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12 : 139 152.[PubMed] [CrossRef]
142. Kuhn R,, Lohler J,, Rennick D,, Rajewsky K,, Muller W . 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 : 263 274.[PubMed] [CrossRef]
143. Kim SC,, Tonkonogy SL,, Albright CA,, Tsang J,, Balish EJ,, Braun J,, Huycke MM,, Sartor RB . 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 : 891 906.[PubMed] [CrossRef]
144. Kim SC,, Tonkonogy SL,, Karrasch T,, Jobin C,, Sartor RB . 2007. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 13 : 1457 1466.[PubMed] [CrossRef]
145. Steck N,, Hoffmann M,, Sava IG,, Kim SC,, Hahne H,, Tonkonogy SL,, Mair K,, Krueger D,, Pruteanu M,, Shanahan F,, Vogelmann R,, Schemann M,, Kuster B,, Sartor RB,, Haller D . 2011. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141 : 959 971.[PubMed] [CrossRef]
146. Cahill RJ,, Foltz CJ,, Fox JG,, Dangler CA,, Powrie F,, Schauer DB . 1997. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus . Infect Immun 65 : 3126 3131.[PubMed]
147. Dieleman LA,, Arends A,, Tonkonogy SL,, Goerres MS,, Craft DW,, Grenther W,, Sellon RK,, Balish E,, Sartor RB . 2000. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun 68 : 5107 5113.[PubMed] [CrossRef]
148. Yang I,, Eibach D,, Kops F,, Brenneke B,, Woltemate S,, Schulze J,, Bleich A,, Gruber AD,, Muthupalani S,, Fox JG,, Josenhans C,, Suerbaum S . 2013. Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS ONE 8 : e70783. [PubMed] [CrossRef]
149. Deriu E,, Liu JZ,, Pezeshki M,, Edwards RA,, Ochoa RJ,, Contreras H,, Libby SJ,, Fang FC,, Raffatellu M . 2013. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14 : 26 37.[PubMed] [CrossRef]
150. Valdebenito M,, Crumbliss AL,, Winkelmann G,, Hantke K . 2006. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int J Med Microbiol 296 : 513 520.[PubMed] [CrossRef]
151. Hibbing ME,, Fuqua C,, Parsek MR,, Peterson SB . 2010. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8 : 15 25.[PubMed] [CrossRef]
152. Cascales E,, Buchanan SK,, Duche D,, Kleanthous C,, Lloubes R,, Postle K,, Riley M,, Slatin S,, Cavard D . 2007. Colicin biology. Microbiol Mol Biol Rev 71 : 158 229.[PubMed] [CrossRef]
153. Riley MA,, Gordon DM . 1999. The ecological role of bacteriocins in bacterial competition. Trends Microbiol 7 : 129 133.[PubMed] [CrossRef]
154. Riley MA,, Gordon DM . 1992. A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages. J Gen Microbiol 138 : 1345 1352.[PubMed] [CrossRef]
155. Nedialkova LP,, Denzler R,, Koeppel MB,, Diehl M,, Ring D,, Wille T,, Gerlach RG,, Stecher B . 2014. Inflammation fuels colicin Ib-dependent competition of Salmonella serovar Typhimurium and E. coli in Enterobacterial blooms. PLoS Pathog 10 : e1003844. [PubMed] [CrossRef]
156. Rakin A,, Saken E,, Harmsen D,, Heesemann J . 1994. The pesticin receptor of Yersinia enterocolitica: a novel virulence factor with dual function. Mol Microbiol 13 : 253 263.[PubMed] [CrossRef]
157. Braun V,, Hantke K,, Koster W . 1998. Bacterial iron transport: mechanisms, genetics, and regulation. Met Ions Biol Syst 35 : 67 145.[PubMed]
158. Butala M,, Zgur-Bertok D,, Busby SJ . 2009. The bacterial LexA transcriptional repressor. Cell Mol Life Sci 66 : 82 93.[PubMed] [CrossRef]
159. Kamensek S,, Podlesek Z,, Gillor O,, Zgur-Bertok D . 2010. Genes regulated by the Escherichia coli SOS repressor LexA exhibit heterogeneous expression. BMC Microbiol 10 : 283. [PubMed] [CrossRef]
160. Mrak P,, Podlesek Z,, van Putten JP,, Zgur-Bertok D . 2007. Heterogeneity in expression of the Escherichia coli colicin K activity gene cka is controlled by the SOS system and stochastic factors. Mol Genet Genomics 277 : 391 401.[PubMed] [CrossRef]
161. Smillie CS,, Smith MB,, Friedman J,, Cordero OX,, David LA,, Alm EJ . 2011. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480 : 241 244.[PubMed] [CrossRef]
162. Kelly BG,, Vespermann A,, Bolton DJ . 2009. Gene transfer events and their occurrence in selected environments. Food Chem Toxicol 47 : 978 983.[PubMed] [CrossRef]
163. Brown Kav A,, Sasson G,, Jami E,, Doron-Faigenboim A,, Benhar I,, Mizrahi I . 2012. Insights into the bovine rumen plasmidome. Proc Natl Acad Sci U S A 109 : 5452 5457.[PubMed] [CrossRef]
164. Stecher B,, Denzler R,, Maier L,, Bernet F,, Sanders MJ,, Pickard DJ,, Barthel M,, Westendorf AM,, Krogfelt KA,, Walker AW,, Ackermann M,, Dobrindt U,, Thomson NR,, Hardt WD . 2012. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 109 : 1269 1274.[PubMed] [CrossRef]
165. Hoiseth SK,, Stocker BA . 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291 : 238 239.[PubMed] [CrossRef]
166. Stecher B,, Chaffron S,, Kappeli R,, Hapfelmeier S,, Freedrich S,, Weber TC,, Kirundi J,, Suar M,, McCoy KD,, von Mering C,, Macpherson AJ,, Hardt WD . 2010. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 6 : e1000711. [PubMed] [CrossRef]
167. Christenson JK,, Gordon DM . 2009. Evolution of colicin BM plasmids: the loss of the colicin B activity gene. Microbiology 155 : 1645 1655.[PubMed] [CrossRef]
168. Reid SD,, Herbelin CJ,, Bumbaugh AC,, Selander RK,, Whittam TS . 2000. Parallel evolution of virulence in pathogenic Escherichia coli . Nature 406 : 64 67.[PubMed] [CrossRef]